Drug profile · INN
diquafosol sodium
DIQUAS
diquafosol sodium (DIQUAS) is a purinergic receptor p2y1 agonist.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — diquafosol sodium
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
diquafosol sodium (DIQUAS) is a purinergic receptor p2y1 agonist.
Key facts
INN diquafosol sodium
Brand DIQUAS
Mechanism Purinergic receptor P2Y1 agonist
Target P2Y purinoceptor 1
Mechanism of action
Purinergic receptor P2Y1 agonist
Primary target: P2Y purinoceptor 1
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is diquafosol sodium?
diquafosol sodium (DIQUAS) is a purinergic receptor p2y1 agonist.
What is the brand name for diquafosol sodium?
DIQUAS is a marketed brand name for diquafosol sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.